Laura Padrón-Barthe

Laura Padrón-Barthe

Auto-generated profile, based on publicly available information

Laura Padrón-Barthe

Global Health Medicines R&D, GlaxoSmithKline

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in JACC
Verified
Journal Article
Closed access
MOMartín F. Ortiz-Genga
Martín F. Ortiz-Genga
SCSofía Cuenca
Sofía Cuenca
MFMatteo Dal Ferro
Matteo Dal Ferro
EZEsther Zorio
Esther Zorio
RSRicardo Salgado-Aranda
Ricardo Salgado-Aranda
LMLorenzo Monserrat
Lorenzo Monserrat

16 October 2014 in Blood
Verified
Journal Article
Open access
PDF file
LPLaura Padrón-Barthe
Laura Padrón-Barthe
STSusana Temiño
Susana Temiño
CCCristina Villa del Campo
Cristina Villa del Campo
LCLaura Carramolino
Laura Carramolino
JIJoan Isern
Joan Isern
MTMiguel Torres
Miguel Torres
Key Points: Single cell lineage tracing shows early separation of blood-endothelial precursors in the mouse embryo. Hemogenic endothelium in the YS generates the blood-endothelial common lineage and produces definitive precursors.

1 May 2016 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
SCSofia Cuenca
Sofia Cuenca
MRMaria J. Ruiz-Cano
Maria J. Ruiz-Cano
Juan Ramón GimenoJuan Ramón Gimeno
Juan Ramón Gimeno
AJAlfonso Jurado
Alfonso Jurado
CSClara Salas
Clara Salas
PGPablo Garcia-Pavia
Pablo Garcia-Pavia

1 June 2016 in JACC
Verified
Journal Article
Closed access
MGMaria Gallego-Delgado
Maria Gallego-Delgado
Juan F. Delgado JiménezJuan F. Delgado Jiménez
Juan F. Delgado Jiménez
VBVicens Brossa-Loidi
Vicens Brossa-Loidi
JPJesús Palomo
Jesús Palomo
RMRaquel Marzoa-Rivas
Raquel Marzoa-Rivas
PGPablo Garcia-Pavia
Pablo Garcia-Pavia

9 March 2006 in Apoptosis
Verified
Journal Article
Closed access
PDF file
JFJ. Fombonne
J. Fombonne
LPL. Padrón
L. Padrón
AEA. Enjalbert
A. Enjalbert
Slavica KranticSlavica Krantic
Slavica Krantic
ATA. Torriglia
A. Torriglia

1 June 2007 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
LPLaura Padron-Barthe
Laura Padron-Barthe
CLChloé Leprêtre
Chloé Leprêtre
EMElisabeth Martin
Elisabeth Martin
MCMarie-France Counis
Marie-France Counis
ATAlicia Torriglia
Alicia Torriglia
The best-characterized biochemical feature of apoptosis is degradation of genomic DNA into oligonucleosomes. The endonuclease responsible for DNA degradation in caspase-dependent apoptosis is caspase-activated DNase. In caspase-independent apoptosis, different endonucleases may be activated according to the cell line and the original insult. Among the known effectors of caspase-independent cell death, L-DNase II (LEI [leukocyte elastase inhibitor]-derived DNase II) has been previously characterized by our laboratory. We have thus shown that this endonuclease derives from the serpin superfamily member LEI by posttranslational modification (A. Torriglia, P. Perani, J. Y. Brossas, E. Chaudun, J. Treton, Y. Courtois, and M. F. Counis, Mol. Cell. Biol. 18:3612-3619, 1998). In this work, we assessed the molecular mechanism involved in the change in the enzymatic activity of this molecule from an antiprotease to an endonuclease. We report that the cleavage of LEI by elastase at its reactive center loop abolishes its antiprotease activity and leads to a conformational modification that exposes an endonuclease active site and a nuclear localization signal. This represents a novel molecular mechanism for a complete functional conversion induced by changing the conformation of a serpin. We also show that this molecular transformation affects cellular fate and that both endonuclease activity and nuclear translocation of L-DNase II are needed to induce cell death.